Biological sex differences in pharmacokinetics and adverse drug reactions
Open accessThe DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.
Abstract
Although physiological and hormonal differences between males and females can significantly alter drug absorption, distribution, metabolism, and excretion (ADME), most current pharmacotherapeutic guidelines remain sex neutral. The chapter aims to elucidate biological sex-specific factors across all pharmacokinetic (PK) phases, subsequent therapeutic efficacy, and adverse drug reactions (ADRs), and to highlight implications for individualized therapy including within-woman variation across the menstrual cycle and other hormonal states. This work is based on an extensive review of current literature and clinical data examining sex-specific variations across all phases of pharmacokinetics. Significant biological sex-related differences were found among all PK phases. Females tend to have slower gastric emptying, higher body fat composition, and lower glomerular filtration rates. CYP3A4 is typically more active in females, while CYP1A2, CYP2D6, and CYP2E1 show greater activity in males. In females, endogenous or exogenous hormonal fluctuation can slightly affect gastric motility, protein binding, and selected CYP activities altering clearance for susceptible drugs. In addition, pregnancy increases plasma volume and glomerular filtration with predictable effects on renally cleared drugs and selected hepatic pathways. These differences influence drug half-life, systemic exposure, and the risk of ADRs. Biological sex is a significant determinant of drug pharmacokinetics. Integrating biological sex-specific data into clinical guidelines is essential to optimize drug efficacy and minimize ADRs. Future research and regulatory action should promote biological sex aware pharmacological practices, encouraging routine inclusion of biological sex analyses in clinical trials. Graphical Abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sex differences in pharmacokinetics and plasticity trajectories remain largely unmapped, despite evidence that network biomarkers and treatment prediction are sensitive to demographic and biological heterogeneity [93,232,233,234].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [233]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · cited 1×
“CYP1A2 contributes to 13% of total CYP liver proteins (Shimada et al. 1994) with caffeine, clozapine, erythromycin and propranolol as well-documented substrates (Scandlyn et al. 2008; Thorn et al. 2012; Grzegorze-wski et al. 2021).”
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Sex bias in neuroscience and biomedical research
Beery, A. K., & Zucker, I. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.002 · Cited by 1,763
Sex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163 · cited 4×
“…prolongs the residence time of drugs in the stomach, potentially delaying absorption kinetics (e.g., metoprolol, theophylline, and verapamil) (Soldin and Mattison 2009; Fletcher et al. 1994; Kimura and Higaki 2002; Fleisher et al. 1999; Xiang et al. 2024; Datz et al. 1987; Knight et al.…”
InfluentialSex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
Waxman, D. J., & Holloway, M. G. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056705 · Cited by 815
Clinical pharmacokinetics and pharmacodynamics of propofol
Sahinovic, M. M., Struys, M. M. R. F., & Absalom, A. R. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0672-3 · Cited by 809 · cited 1×
“The Vd of diazepam in females is reported as 1.87 L/kg compared to 1.34 L/kg in males, leading to prolonged drug half-life and extended sedative effects in women (Routledge et al. 1981; Ochs et al. 1981; Greenb-latt et al. 1980; Sahinovic et al. 2018; Hoymork and Raeder 2005).”
InfluentialPharmacokinetics of Monoclonal Antibodies
Ryman, J. T., & Meibohm, B. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12224 · Cited by 802
Almazroo, O. A., Miah, M. K., & Venkataramanan, R. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.001 · Cited by 681
Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
Lennard, L., Lilleyman, J. S., Van Loon, J., & Weinshilboum, R. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)91745-v · Cited by 651
Drug Transfer and Metabolism by the Human Placenta
Syme, M. R., Paxton, J. W., & Keelan, J. A. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443080-00001 · Cited by 634
Effects of Obesity on Pharmacokinetics: Implications for Drug Therapy
Cheymol, G. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039030-00004 · Cited by 631
Thummel, K. E., O'Shea, D., Paine, M. F., Shen, D. D., Kunze, K. L., Perkins, J. D., & Wilkinson, G. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90177-0 · Cited by 617
PHASE II DRUG METABOLIZING ENZYMES
Jancova, P., Anzenbacher, P., & Anzenbacherova, E. (2010) · Biomedical Papers · doi:10.5507/bp.2010.017 · Cited by 603
Gender Differences in Pharmacokinetics of Alcohol
Baraona, E., Abittan, C. S., Dohmen, K., Moretti, M., Pozzato, G., Chayes, Z. W., Schaefer, C., & Lieber, C. S. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200104000-00004 · Cited by 579
Olanzapine: Pharmacokinetic and Pharmacodynamic Profile
Callaghan, J. T., Bergstrom, R. F., Ptak, L. R., & Beasley, C. M. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937030-00001 · Cited by 544
Sex Differences in Pharmacokinetics and Pharmacodynamics
Gandhi, M., Aweeka, F., Greenblatt, R. M., & Blaschke, T. F. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121453 · Cited by 542
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
Zhou, S., Yung Chan, S., Cher Goh, B., Chan, E., Duan, W., Huang, M., & McLeod, H. L. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544030-00005 · Cited by 517
Fleisher, D., Li, C., Zhou, Y., Pao, L., & Karim, A. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936030-00004 · Cited by 506
The Influence of Sex on Pharmacokinetics
Schwartz, J. B. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342020-00001 · Cited by 467
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy
Tracy, T. S., Venkataramanan, R., Glover, D. D., & Caritis, S. N. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.08.030 · Cited by 448
Custodio, J. M., Wu, C.-Y., & Benet, L. Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.043 · Cited by 434
Effect of age and gender on the activity of human hepatic CYP3A
Hunt, C. M., Westerkam, W. R., & Stave, G. M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90010-g · Cited by 426
Gorski, J. C., Jones, D. R., Haehner-Daniels, B. D., Hamman, M. A., O'Mara, E. M., & Hall, S. D. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90146-1 · Cited by 411
Current trends in drug metabolism and pharmacokinetics
Li, Y., Meng, Q., Yang, M., Liu, D., Hou, X., Tang, L., Wang, X., Lyu, Y., Chen, X., Liu, K., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.10.001 · Cited by 391
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
Liu, L. (2018) · Protein & Cell · doi:10.1007/s13238-017-0408-4 · Cited by 390
Johnell, K., & Klarin, I. (2007) · Drug Safety · doi:10.2165/00002018-200730100-00009 · Cited by 386
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Englund, G., Rorsman, F., Rönnblom, A., Karlbom, U., Lazorova, L., Gråsjö, J., Kindmark, A., & Artursson, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.010 · Cited by 368
Reference values for resting blood flow to organs of man
Williams, L. R., & Leggett, R. W. (1989) · Clinical Physics and Physiological Measurement · doi:10.1088/0143-0815/10/3/001 · Cited by 356
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
Centanni, M., Moes, D. J. A. R., Trocóniz, I. F., Ciccolini, J., & van Hasselt, J. G. C. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00748-2 · Cited by 355
Diazepam disposition determinants
Greenblatt, D. J., Allen, M. D., Harmatz, J. S., & Shader, R. I. (1980) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1980.40 · Cited by 348
Watkins, P. B., Murray, S. A., Winkelman, L. G., Heuman, D. M., Wrighton, S. A., & Guzelian, P. S. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113933 · Cited by 345
Sex Differences in Drug Disposition
Soldin, O. P., Chung, S. H., & Mattison, D. R. (2011) · BioMed Research International · doi:10.1155/2011/187103 · Cited by 341
Renal hemodynamics and tubular function in normal human pregnancy
Davison, J. M., & Dunlop, W. (1980) · Kidney International · doi:10.1038/ki.1980.124 · Cited by 338
Goetz, M. P., Sangkuhl, K., Guchelaar, H., Schwab, M., Province, M., Whirl‐Carrillo, M., Symmans, W. F., McLeod, H. L., Ratain, M. J., Zembutsu, H., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1007 · Cited by 336
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
Fasanmade, A. A., Adedokun, O. J., Ford, J., Hernandez, D., Johanns, J., Hu, C., Davis, H. M., & Zhou, H. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0718-4 · Cited by 327
Gu, L., Gonzalez, F. J., Kalow, W., & Tang, B. K. (1992) · Pharmacogenetics · doi:10.1097/00008571-199204000-00004 · Cited by 326
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2* activities
Relling, M. V., Lin, J.-S., Ayers, G. D., & Evans, W. E. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.203 · Cited by 314
Drug-Induced QT Prolongation in Women During the Menstrual Cycle
Rodriguez, I. (2001) · JAMA · doi:10.1001/jama.285.10.1322 · Cited by 311
Gender-related differences in gastric emptying.
Datz, F. L., Christian, P. E., & Moore, J. G. (1987) · PubMed · Cited by 282
Influence of sex and age on fluorouracil clearance.
Milano, G., Etienne, M. C., Cassuto-Viguier, E., Thyss, A., Santini, J., Frenay, M., Renee, N., Schneider, M., & Demard, F. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1171 · Cited by 260
Hebert, M., Easterling, T., Kirby, B., Carr, D., Buchanan, M., Rutherford, T., Thummel, K., Fishbein, D., & Unadkat, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.1 · Cited by 259
Hebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252 · cited 2×
“…is increased during pregnancy, influencing the metabolism of drugs like midazolam, phenytoin, glyburide, nifedipine, and nelfinavir (Hebert et al. 2008; Hirt et al. 2006; Villani et al. 2006; Tracy et al. 2005; Carter et al. 1986; Quinney et al. 2012; Dickinson et al. 1989; Hebert et al. 2009).”
Human liver catechol-O-methyltransferase pharmacogenetics
Boudíková, B., Szumlanski, C., Maidak, B., & Weinshilboum, R. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.166 · Cited by 248
Müller, C., Murawski, N., Wiesen, M. H. J., Held, G., Poeschel, V., Zeynalova, S., Wenger, M., Nickenig, C., Peter, N., Lengfelder, E., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380949 · Cited by 242
Rasmussen (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00008 · Cited by 241
Warfarin Maintenance Dosing Patterns in Clinical Practice
Garcia, D., Regan, S., Crowther, M., Hughes, R. A., & Hylek, E. M. (2005) · Chest · doi:10.1378/chest.127.6.2049 · Cited by 241
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins
Wiegratz, I., Kutschera, E., Lee, J. H., Moore, C., Mellinger, U., Winkler, U. H., & Kuhl, H. (2003) · Contraception · doi:10.1016/s0010-7824(02)00436-5 · Cited by 239 · cited 2×
“Additionally, AAG, which binds weakly basic drugs, displays lower levels in females due to lower synthesis mediated by estrogen (Englund et al. 2006; Wiegratz et al. 2003; Walle et al. 1983; Piafsky and Borga 1977; Kishino et al. 1995).”
Sex hormones and their receptors regulate liver energy homeostasis
Shen, M., & Shi, H. (2015) · International Journal of Endocrinology · doi:10.1155/2015/294278 · Cited by 239 · cited 2×
“These variations include differences in gastrointestinal (GI) motility, hepatic enzyme activity, fat-to-lean body ratio, plasma protein binding, and renal clearance (Kasarinaite et al. 2023; Gerges and El-Kadi 2023; Shen and Shi 2015).”
ADME/PK as part of a rational approach to drug discovery
Eddershaw, P. J., Beresford, A. P., & Bayliss, M. K. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01540-3 · Cited by 237
Plasma protein binding of basic drugs
Piafsky, K. M., & Borga, O. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977225part1545 · Cited by 232
Sex differences in antidepressant efficacy
LeGates, T. A., Kvarta, M. D., & Thompson, S. M. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0156-z · Cited by 230
Age and sex variation in serum albumin concentration: an observational study.
Weaving, G., Batstone, G. F., & Jones, R. G. (2016) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/0004563215593561 · Cited by 229
PLASMA VOLUME IN NORMAL FIRST PREGNANCY
Pirani, B. B. K., Campbell, D. M., & MacGillivray, I. (1973) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1973.tb02146.x · Cited by 229
Berg, U. B. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl227 · Cited by 223
Lamotrigine plasma levels reduced by oral contraceptives
Sabers, A., Buchholt, J. M., Uldall, P., & Hansen, E. L. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00305-9 · Cited by 219 · cited 1×
“OCs are known to increase the glucuronidation clearance of drugs such as clofibrate (Miners et al. 1984; Liu et al. 1991), propranolol (Walle et al. 1996), phenpro-coumon (Monig et al. 1990), diflunisal (Herman et al. 1994), and lamotrigine (Sabers et al. 2001).”
Szumlanski, C. L., Honchel, R., Scott, M. C., & Weinshilboum, R. M. (1992) · Pharmacogenetics · doi:10.1097/00008571-199208000-00002 · Cited by 215
Pharmacokinetic drug interactions with oral contraceptives
Back, D. J., & Orme, M. L. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018060-00004 · Cited by 209
Gastrointestinal Transit and Drug Absorption
Kimura, T., & Higaki, K. (2002) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.25.149 · Cited by 205
Jones, A. W. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.02.021 · Cited by 205
Drug metabolism and pharmacokinetics
Benedetti, M. S., Whomsley, R., Poggesi, I., Cawello, W., Mathy, F.-X., Delporte, M.-L., Papeleu, P., & Watelet, J.-B. (2009) · Drug Metabolism Reviews · doi:10.1080/10837450902891295 · Cited by 201
Bock, K. W., Schrenk, D., Forster, A., Griese, E.-U., M??rike, K., Brockmeier, D., & Eichelbaum, M. (1994) · Pharmacogenetics · doi:10.1097/00008571-199408000-00005 · Cited by 199
Sex-specific differences in CYP450 isoforms in humans
Scandlyn, M. J., Stuart, E. C., & Rosengren, R. J. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.4.413 · Cited by 199
Gestation-induced changes in lamotrigine pharmacokinetics: A monotherapy study
de Haan, G. J., Edelbroek, P., Segers, J., Engelsman, M., Lindhout, D., Dévilé-Notschaele, M., & Augustijn, P. (2004) · Neurology · doi:10.1212/01.wnl.0000133213.10244.fd · Cited by 197
Impairment of Caffeine Clearance by Chronic Use of Low-Dose Oestrogen-Containing Oral Contraceptives
Abernethy, D. R., & Todd, E. L. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544361 · Cited by 195 · cited 1×
“…and Orme 1990; Meffin et al. 1984; Abernethy et al. 1982b; Abernethy et al. 1984; Edelbroek et al. 1987; Sandberg et al. 2004; Granfors et al. 2005; Matthaei et al. 2016; Abernethy and Todd 1985; Gu et al. 1992; Tornatore et al. 1982; Tamminga et al. 1999; Laine et al. 1999; Bram-ness et al. 2005).”
Increased Expression of the Cardiac L-type Calcium Channel in Estrogen Receptor–deficient Mice
Johnson, B. D., Zheng, W., Korach, K. S., Scheuer, T., Catterall, W. A., & Rubanyi, G. M. (1997) · The Journal of General Physiology · doi:10.1085/jgp.110.2.135 · Cited by 188
Gender differences in antidepressant drug response
Keers, R., & Aitchison, K. J. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.496448 · Cited by 185
Pharmacokinetic and Pharmacologic Variation Between Different Estrogen Products
O'Connell, M. B. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04143.x · Cited by 184
Influence of sex and oral contraceptive steroids on paracetamol metabolism.
Miners, J., Attwood, J., & Birkett, D. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02207.x · Cited by 184
Self-catalyzed inactivation of hepatic cytochrome P-450 by ethynyl substrates.
Ortiz de Montellano, P. R., & Kunze, K. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70669-3 · Cited by 178
Effects of Cimetidine on Gastric Alcohol Dehydrogenase Activity and Blood Ethanol Levels
Caballeria, J., Baraona, E., Rodamilans, M., & Lieber, C. S. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91562-x · Cited by 174
Grosso, L. M., & Bracken, M. B. (2005) · Annals of Epidemiology · doi:10.1016/j.annepidem.2004.12.011 · Cited by 173
ALCOHOL EFFECTS IN WOMEN DURING THE MENSTRUAL CYCLE*
Jones, B. M., & Jones, M. K. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb52931.x · Cited by 170
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics
Lew, K. H., Ludwig, E. A., Milad, M. A., Donovan, K., Jr., E. M., Ferry, J. J., & Jusko, W. J. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.167 · Cited by 169
Body Fat and Water Changes During Pregnancy in Women With Different Body Weight and Weight Gain
LEDERMAN, S. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00355-4 · Cited by 168
Tamminga, W. J., Wemer, J., Oosterhuis, B., Wieling, J., Wilffert, B., de Leij, L. F. M. H., de Zeeuw, R. A., & Jonkman, J. H. G. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050615 · Cited by 166
Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: An updated review
Bigos, K. L., Pollock, B. G., Stankevich, B. A., & Bies, R. R. (2009) · Gender Medicine · doi:10.1016/j.genm.2009.12.004 · Cited by 164
Frye, C. A., & Duncan, J. E. (1994) · Brain Research · doi:10.1016/0006-8993(94)90025-6 · Cited by 163
Sex-based differences in drug activity.
Whitley, H. P., & Lindsey, W. (2009) · PubMed · Cited by 162
Caldwell, J., Gardner, I., & Swales, N. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300202 · Cited by 160
Lane, H.-Y., Chang, Y.-C., Chang, W.-H., Lin, S.-K., Tseng, Y.-T., & Jann, M. W. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0108 · Cited by 158
Murphy, M. M., Scott, J. M., McPartlin, J. M., & Fernandez-Ballart, J. D. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.3.614 · Cited by 158
The Relative Efficacy and Safety of Clopidogrel in Women and Men
Berger, J. S., Bhatt, D. L., Cannon, C. P., Chen, Z., Jiang, L., Jones, J. B., Mehta, S. R., Sabatine, M. S., Steinhubl, S. R., Topol, E. J., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.074 · Cited by 157
Pharmacokinetics of caffeine during and after pregnancy
Brazier, J. L., Ritter, J., Berland, M., Khenfer, D., & Faucon, G. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457332 · Cited by 155
Stephen, A. M., Wiggins, H. S., Englyst, H. N., Cole, T. J., Wayman, B. J., & Cummings, J. H. (1986) · British Journal of Nutrition · doi:10.1079/bjn19860116 · Cited by 154
Kim, R. B., O'Shea, D., & Wilkinson, G. R. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90227-9 · Cited by 153
Interpreting Tacrolimus Concentrations During Pregnancy and Postpartum
Hébert, M. F., Zheng, S., Hays, K. E., Shen, D. D., Davis, C. L., Umans, J. G., Miodovnik, M., Thummel, K. E., & Easterling, T. R. (2012) · Transplantation · doi:10.1097/tp.0b013e318278d367 · Cited by 150
Lucas, D., M??nez, C., Girre, C., Berthou, F., Bod??nez, P., Joannet, I., Hispard, E., Bardou, L.-G., & M??nez, J.-F. (1995) · Pharmacogenetics · doi:10.1097/00008571-199510000-00005 · Cited by 150
Suboptimal dosing of rituximab in male and female patients with DLBCL
Pfreundschuh, M. G., Müller, C., Zeynalova, S., Kuhnt, E., Wiesen, M. H. J., Held, G., Rixecker, T., Poeschel, V., Zwick, C., Reiser, M., et al. (2013) · Blood · doi:10.1182/blood-2013-07-517037 · Cited by 144
Lc, K., Hp, P., Kl, B., Miller, M. A., Trate, D. M., Maurer, A. H., & Fisher, R. S. (1997) · PubMed · Cited by 142
EFFECT OF GENDER AND SEX HORMONES ON VASCULAR OXIDATIVE STRESS
Miller, A. A., De Silva, T. M., Jackman, K. A., & Sobey, C. G. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04732.x · Cited by 141
The ABCD of clinical pharmacokinetics
Doogue, M. P., & Polasek, T. M. (2013) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098612469335 · Cited by 140
Anderson, P. L., Kakuda, T. N., Kawle, S. P., & Fletcher, C. V. (2003) · AIDS · doi:10.1097/00002030-200310170-00003 · Cited by 138
Plasma Protein Binding of Drugs in Pregnancy
Perucca, E., & Crema, A. (1982) · Clinical Pharmacokinetics · doi:10.2165/00003088-198207040-00004 · Cited by 134
Kuip, E. J. M., Zandvliet, M. L., Koolen, S. L. W., Mathijssen, R. H. J., & van der Rijt, C. C. D. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13129 · Cited by 134
Phenotypic polymorphism and gender‐related differences of CYP1A2 activity in a Chinese population
Ou‐Yang, D., Huang, S., Wang, W., Xie, H., Xu, Z., Shu, Y., & Zhou, H. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00128.x · Cited by 133
Gender differences in human pharmacokinetics and pharmacodynamics
Fletcher, C. V., Acosta, E. P., & Strykowski, J. M. (1994) · Journal of Adolescent Health · doi:10.1016/s1054-139x(94)90628-9 · Cited by 133
Pharmacokinetics of Ampicillin during Pregnancy
Philipson, A. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.3.370 · Cited by 132
Obesity, sex, and acetaminophen disposition
Abernethy, D. R., Divoll, M., Greenblatt, D. J., & Ameer, B. (1982) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1982.111 · Cited by 131
Impairment of Diazepam Metabolism by Low-Dose Estrogen-Containing Oral-Contraceptive Steroids
Abernethy, D. R., Greenblatt, D. J., Divoll, M., Arendt, R., Ochs, H. R., & Shader, R. I. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204013061307 · Cited by 130
Maternal kidney function during pregnancy: systematic review and meta‐analysis
Lopes van Balen, V. A., van Gansewinkel, T. A. G., de Haas, S., Spaan, J. J., Ghossein‐Doha, C., van Kuijk, S. M. J., van Drongelen, J., Cornelis, T., & Spaanderman, M. E. A. (2019) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.20137 · Cited by 129
Gender difference in antidiuretic response to desmopressin
Juul, K. V., Klein, B. M., Sandström, R., Erichsen, L., & Nørgaard, J. P. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00741.2010 · Cited by 128
The Influence of Sex Hormones in Liver Function and Disease
Kasarinaite, A., Sinton, M., Saunders, P. T. K., & Hay, D. C. (2023) · Cells · doi:10.3390/cells12121604 · Cited by 127
Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects
Walle, T., Walle, U. K., Cowart, T. D., & Conradi, E. C. (1989) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1989.136 · Cited by 126
Tsutsumi, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.116495 · Cited by 124
PharmGKB summary: caffeine pathway
Thorn, C. F., Aklillu, E., McDonagh, E. M., Klein, T. E., & Altman, R. B. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283505d5e · Cited by 121
Shi, J., Wang, X., Nguyen, J., Bleske, B. E., Liang, Y., Liu, L., & Zhu, H. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.003 · Cited by 120
Clinical pharmacokinetics and pharmacogenetics of tamoxifen and endoxifen
Sanchez‐Spitman, A., Swen, J. J., Dezentjé, V. O., Moes, D. J. A. R., Gelderblom, H. A. J., & Guchelaar, H. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1610390 · Cited by 120
Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry
Dobbs, N. A., Twelves, C. J., Gillies, H., James, C. A., Harper, P., & Rubens, R. D. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685796 · Cited by 117
Gender‐Specific Effects on Verapamil Pharmacokinetics and Pharmacodynamics in Humans
Krecic‐Shepard, M. E., Barnas, C. R., Slimko, J., Jones, M. P., & Schwartz, J. B. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008883 · Cited by 116
Zalcberg, J. R., Kerr, D. J., Seymour, L. W., & Palmer, M. K. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00259-7 · Cited by 115
Lithium and Pregnancy—II, Hazards to Women Given Lithium During Pregnancy and Delivery
Schou, M., Amdisen, A., & Steenstrup, O. R. (1973) · BMJ · doi:10.1136/bmj.2.5859.137 · Cited by 115
Court, M. H., Hao, Q., Krishnaswamy, S., Bekaii‐Saab, T., Al-Rohaimi, A., Moltke, L. L., & Greenblatt, D. J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067660 · Cited by 115
Diazepam Kinetics in Relation to Age and Sex
Ochs, H. R., Greenblatt, D. J., Divoll, M., Abernethy, D. R., Feyerabend, H., & Dengler, H. J. (1981) · Pharmacology · doi:10.1159/000137524 · Cited by 114
GRANFORS, M., BACKMAN, J., LAITILA, J., & NEUVONEN, P. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.009 · Cited by 113
Gender Has a Small but Statistically Significant Effect on Clearance of CYP3A Substrate Drugs
Greenblatt, D. J., & von Moltke, L. L. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008323754 · Cited by 112
Duan, L.-P., Wang, H. H., Ohashi, A., & Wang, D. Q.-H. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00172.2005 · Cited by 111
Cardiovascular Pharmacotherapeutic Considerations During Pregnancy and Lactation
Qasqas, S. A., McPherson, C., Frishman, W. H., & Elkayam, U. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000102420.62200.e1 · Cited by 111
Why do women wake up faster than men from propofol anaesthesia?
Høymork, S. C., & Raeder, J. C. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei245 · Cited by 111
Stereoselective binding of propranolol to human plasma, α1-acid glycoprotein, and albumin
Walle, U. K., Walle, T., Bai, S. A., & Olanoff, L. S. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.240 · Cited by 110
Grzegorzewski, J., Bartsch, F., Köller, A., & König, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.752826 · Cited by 108
Gender and interindividual variability in pharmacokinetics
Nicolas, J.-M., Espie, P., & Molimard, M. (2009) · Drug Metabolism Reviews · doi:10.1080/10837450902891485 · Cited by 108
DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
Paine, M. F., Ludington, S. S., Chen, M.-L., Stewart, P. W., Huang, S.-M., & Watkins, P. B. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002469 · Cited by 108
Effect of age and sex on the plasma binding of acidic and basic drugs
Verbeeck, R. K., Cardinal, J.-A., & Wallace, S. M. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00553161 · Cited by 104
Race and sex influence clearance of nifedipine: Results of a population study
Krecic-Shepard, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108678 · Cited by 104
Effect of age and sex on the plasma binding of acidic and basic drugs
Verbeeck, R. K., Cardinal, J.-A., & Wallace, S. M. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf02395213 · Cited by 98
Body composition and resting metabolic rate: the myth of feminine metabolism
Cunningham, J. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.4.721 · Cited by 97
Hormonal Regulation of Hepatic Drug-Metabolizing Enzyme Activity During Adolescence
Kennedy, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.202 · Cited by 95
Eugster, H. P., Probst, M., Würgler, F. E., & Sengstag, C. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07334-9 · Cited by 94
Verapamil protein binding in patients and in normal subjects
Keefe, D. L., Yee, Y., & Kates, R. E. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.4 · Cited by 93
Fasting gastric pH and its relationship to true hypochlorhydria in humans
Feldman, M. L., & Barnett, C. C. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297133 · Cited by 92
Effects of Age, Gender and Oral Contraceptives on Intramuscular Midazolam Pharmacokinetics
Holazo, A. A., Winkler, M. B., & Patel, I. H. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03127.x · Cited by 84
Vahl, N. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3612 · Cited by 84
The population pharmacokinetics of long‐term methotrexate in rheumatoid arthritis
Godfrey, C. J., Sweeney, K., Miller, K., Hamilton, R. A., & Kremer, J. M. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.t01-1-00790.x · Cited by 84
Sex‐related differences in the plasma protein binding of lignocaine and diazepam.
Routledge, P., Stargel, W., Kitchell, B., Barchowsky, A., & Shand, D. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb00528.x · Cited by 82
Parlesak, A. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.4.388 · Cited by 81
Inhibition of oral contraceptive steroid—metabolizing enzymes by steroids and drugs
Guengerich, F. P. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90557-n · Cited by 80
Population pharmacokinetics of bevacizumab in cancer patients with external validation
Han, K., Peyret, T., Marchand, M., Quartino, A. L., Gosselin, N. H., Girish, S., Allison, D. E., & Jin, J. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3079-6 · Cited by 80
Walle, T., Byington, R. P., Furberg, C. D., McIntyre, K. M., & Vokonas, P. S. (1985) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1985.216 · Cited by 78
Patient Sex and its Influence on General Anaesthesia
Buchanan, F. F., Myles, P. S., & Cicuttini, F. (2009) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0903700201 · Cited by 77
Fisher, M. M., & Yousef, I. M. (1973) · PubMed · Cited by 76
Gerges, S. H., & El‐Kadi, A. O. S. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000915 · Cited by 76
Gex‐Fabry, M., Balant-Gorgia, A. E., Balant, L. P., & Garrone, G. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019030-00007 · Cited by 75
Zolpidem and Gender: Are Women Really At Risk?
Greenblatt, D. J., Harmatz, J. S., & Roth, T. (2019) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001026 · Cited by 75
Dahl, M. L., Bertilsson, L., & Nordin, C. (1996) · Psychopharmacology · doi:10.1007/bf02246640 · Cited by 75
Sex Differences in the Metabolism of Ethanol and Acetaldehyde in Normal Subjects
Arthur, M. J. P., Lee, A., & Wright, R. (1984) · Clinical Science · doi:10.1042/cs0670397 · Cited by 75
Mai, Y., Liu, D., Yao, Z., Madla, C. M., Gavins, F. K. H., Taherali, F., Yin, H., Orlu, M., Murdan, S., & Basit, A. W. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00574 · Cited by 75
Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative Review
Romanescu, M., Buda, V. O., Lombrea, A., Andor, M., Ledeţi, I., Suciu, M., Danciu, C., Dehelean, C. A., & Dehelean, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060907 · Cited by 74
Absorption and disposition of ibuprofen in the elderly
Greenblatt, D. J., Abernethy, D. R., Matlis, R., Harmatz, J. S., & Shader, R. I. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270918 · Cited by 69
Interethnic difference in thiopurine methyltransferase activity
Klemetsdal, B., Tollefsen, E., Loennechen, T., Johnsen, K., Utsi, E., Gisholt, K., Wist, E., & Aarbakke, J. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.4 · Cited by 69
Age and gender influence the stereoselective pharmacokinetics of propranolol.
Gilmore, D. A., Gal, J., Gerber, J. G., & Nies, A. S. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11136-1 · Cited by 68
Imipramine disposition in users of oral contraceptive steroids
Abernethy, D. R., Greenblatt, D. J., & Shader, R. I. (1984) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1984.114 · Cited by 67
Relative Importance of Dose, Body Surface Area, Sex, and Age for 5-Fluorouracil Clearance
Port, R. E., Daniel, B., Ding, R. W., & Herrmann, R. (2009) · Oncology · doi:10.1159/000226942 · Cited by 67
Pharmacokinetics and Pharmacodynamics of Atenolol During Pregnancy and Postpartum
Hebert, M. F., Carr, D. B., Anderson, G. D., Blough, D., Green, G. E., Brateng, D. A., Kantor, E., Benedetti, T. J., & Easterling, T. R. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004269704 · Cited by 66
Gender Is an Important Determinant of the Disposition of the Loop Diuretic Torasemide
Werner, U., Werner, D., Heinbüchner, S., Graf, B., Ince, H., Kische, S., Thürmann, P., König, J., Fromm, M. F., & Zolk, O. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009337514 · Cited by 66
Balogh, A., Henschel, L., Klinger, G., Vollanth, R., B�rner, A., & Kuhnz, W. (1995) · European Journal of Clinical Pharmacology · doi:10.1007/bf00192743 · Cited by 66
Gaudry, S. E., Sitar, D. S., Smyth, D. D., McKenzie, J. K., & Aoki, F. Y. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.104 · Cited by 66
Yin, O., Xiong, Y., Endo, S., Yoshihara, K., Garimella, T., AbuTarif, M., Wada, R., & LaCreta, F. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2096 · Cited by 65
Effects of oral contraceptive steroids on acetaminophen metabolism and elimination
Mitchell, M. C., Hanew, T., Meredith, C. G., & Schenker, S. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.127 · Cited by 64
Harris, R. Z., Tsunoda, S. M., Mroczkowski, P., Wong, H., & Benet, L. Z. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90112-5 · Cited by 64
Pharmacokinetics of nelfinavir in HIV‐1‐infected pregnant and nonpregnant women
Villani, P., Floridia, M., Pirillo, M. F., Cusato, M. P., Tamburrini, E., Cavaliere, A. F., Guaraldi, G., Vanzini, C., Molinari, A., Antoni, A. D., et al. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02669.x · Cited by 64
Hayashi, M., Ueda, Y., Hoshimoto, K., Ota, Y., Fukasawa, I., Sumori, K., Kaneko, I., Shirou, A. B. E., Uno, M., Ohkura, T., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.30561 · Cited by 63
Anderson, G. D. (2002) · PubMed · Cited by 63
Influence of menstrual cycle and gender on alprazolam pharmacokinetics
Kirkwood, C., Moore, A., Hayes, P., DeVane, C. L., & Pelonero, A. (1991) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1991.157 · Cited by 62
Erythrocyte catechol‐O‐methyltransferase activity in a Swedish population
Floderus, Y., Ross, S. B., & Wetterberg, L. (1981) · Clinical Genetics · doi:10.1111/j.1399-0004.1981.tb00731.x · Cited by 61
Palovaara, S., Tybring, G., & Laine, K. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01868.x · Cited by 61
Effect of chronic oral contraceptive steroids on theophylline disposition
Tornatore, K. M., Kanarkowski, R., McCarthy, T. L., Gardner, M. J., Yurchak, A. M., & Jusko, W. J. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00545966 · Cited by 60
Urinary excretion of some proteins and enzymes during normal pregnancy.
Cheung, C. K., Lao, T. T.-H., & Swaminathan, R. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.9.1978 · Cited by 59
Levodopa pharmacokinetics and dyskinesias: are there sex-related differences?
Martinelli, P., Contin, M., Scaglione, C. L. M., Riva, R., Albani, F., & Baruzzi, A. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0125-z · Cited by 59
Effect of hepatic dysfunction on oral cyclosporin pharmacokinetics in marrow transplant patients
Yee, G. C., Kennedy, M., Storb, R. F., & Thomas, E. D. (1984) · Blood · doi:10.1182/blood.v64.6.1277.1277 · Cited by 57
THE IMPACT OF CYP2C9 GENETICS AND ORAL CONTRACEPTIVES ON CYTOCHROME P450 2C9 PHENOTYPE
Sandberg, M., Johansson, I., Christensen, M., Rane, A., & Eliasson, E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.5.484 · Cited by 57
Miners, J., Robson, R., & Birkett, D. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02461.x · Cited by 56
Sex Differences in the Pharmacokinetics of Levodopa in Elderly Patients With Parkinson Disease
Kumagai, T., Nagayama, H., Ota, T., Nishiyama, Y., Mishina, M., & Ueda, M. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000051 · Cited by 56
Yukawa, E., Mine, H., Higuchi, S., & Aoyama, T. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb05515.x · Cited by 55
Adamus, M., Gabrhelík, T., & Marek, O. (2008) · European Journal of Anaesthesiology · doi:10.1017/s026502150800402x · Cited by 55
Pharmacokinetics of Clindamycin in Pregnant Women in the Peripartum Period
Muller, A. E., Mouton, J. W., Oostvogel, P. M., Dörr, P. J., Voskuyl, R. A., DeJongh, J., Steegers, E. A. P., & Danhof, M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01017-09 · Cited by 55
Sex differences in absorption kinetics of sodium salicylate
Miaskiewicz, S., Shively, C. A., & Vesell, E. S. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.5 · Cited by 54
Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy
Allegaert, K., Mieghem, T. V., Verbesselt, R., Hoon, J. N. J. M. D., Rayyan, M., Devlieger, R., Deprest, J. A., & Anderson, B. J. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.08.067 · Cited by 54
Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics
Bruguerolle, B., Toumi, M., Faraj, E., VERVLOET, D., & Razzouka, H. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf02657059 · Cited by 54
Gupta, S. K., Atkinson, L. E., Tu, T., & Ja, L. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04554.x · Cited by 53
Pharmacokinetics of ampicillin and sulbactam in pregnancy
Chamberlain, A., White, S., Bawdon, R. E., Thomas, S., & Larsen, B. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90515-k · Cited by 52
Moyle, G. J., Boffito, M., Fletcher, C., Higgs, C., Hay, P., Song, I. H., Lou, Y., Yuen, G. J., Min, S., & Guerini, E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01000-08 · Cited by 51
The effect of gender on the pharmacokinetics of verapamil and norverapamil in human
Dadashzadeh, S., Javadian, B., & Sadeghian, S. (2006) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.512 · Cited by 51
Strandell, J., & Wahlin, S. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0979-y · Cited by 50
Roberts, J. L., Desai, N., McCoy, J. M., & Goren, A. (2014) · Dermatologic Therapy · doi:10.1111/dth.12130 · Cited by 50
Effects of age and gender on pharmacokinetics of cefepime
Barbhaiya, R. H., Knupp, C. A., & Pittman, K. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.6.1181 · Cited by 49
Review of Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents
Estes, L. L. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.11.1114 · Cited by 47
WEDEL, M., PIETERS, J. E., PIKAAR, N. A., & OCKHUIZEN, T. (1991) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045119 · Cited by 47
Sex differences in antiplatelet therapy: state-of-the art
Gąsecka, A., Zimodro, J. M., & Appelman, Y. (2023) · Platelets · doi:10.1080/09537104.2023.2176173 · Cited by 47
Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms
Shi, J., Wang, X., Eyler, R. F., Liang, Y., Liu, L., Mueller, B. A., & Zhu, H. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12625 · Cited by 46
Yukawa, E., Honda, T., Ohdo, S., Higuchi, S., & Aoyama, T. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04766.x · Cited by 45
Theophylline clearance during pregnancy.
Bl, C., Driscoll, C. E., & Smith, G. D. (1986) · PubMed · Cited by 45
Sex-related differences in theophylline pharmacokinetics
Nafziger, A. N., & Bertino, J. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609434 · Cited by 44
Effect of age and sex on glomerular filtration rate measured by 51Cr-EDTA.
Gross, J. L., Friedman, R., de Azevedo, M. J., Silveiro, S. P., & Pecis, M. (1992) · PubMed · Cited by 44
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson’s Disease
Conti, V., Izzo, V., Russillo, M. C., Picillo, M., Amboni, M., Scaglione, C. L. M., Nicoletti, A. S. Q., Cani, I., Cicero, C. E., Bellis, E. D., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.909936 · Cited by 43
Laine, K., Anttila, M. I., Helminen, A., Karnani, H., & Huupponen, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00891.x · Cited by 42
Pregnancy-Related Effects on Nelfinavir-M8 Pharmacokinetics: a Population Study with 133 Women
Hirt, D., Tréluyer, J., Jullien, V., Firtion, G., Chappuy, H., Rey, E., Pons, G., Mandelbrot, L., & Urien, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01596-05 · Cited by 41
The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin.
Dickinson, R., Hooper, W., Wood, B., Lander, C., & Eadie, M. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03501.x · Cited by 38
Research works printed but not linked: 2
- FDA Drug Safety Communication (2013) FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR [press release]. FDA
- Onetto AJ, Sharif S (2025) Drug distribution. StatPearls. Treasure Island (FL) 33620813
Cited by
Araújo, M. R., Mendes‐Frias, A., & Silvestre, R. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00857-1 · Cited by 12
Wang, F., Li, Y., Feng, X., Shu, Y., Zhang, C., Li, L., & Guo, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149406 · Cited by 4
Seifert, J., Grohmann, R., Toto, S., Reinhard, M. A., Bleich, S., Erfurth, A., Schüle, C., Stübner, S., & Glocker, C. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04900-7 · Cited by 5
Neamah, A. S., & Lafta, F. M. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05046-w · Cited by 2
Medication adherence in adolescents: physiological, psychosocial, and clinical perspectives
Kırmızı, N. İ., Akıcı, N., & Akıcı, A. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05122-1 · Cited by 4
Metadata
- Authors
- Aljohmani, A., & Yildiz, D.
- Affiliations
- Saarland University (DE)
- Corresponding author
- Yildiz, Daniela
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2025-10-21
- Volume
- 399
- Issue
- 3
- Pages
- 3285-3301
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- PMC
- PMC12935741
- OpenAlex
- W4415378844
- Cited by
- 35
- References
- 248
- Citations by year
- 2026: 33 · 2025: 2
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- Universität des Saarlandes
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- sex differences, pharmacokinetics, adverse drug reactions, drug absorption, drug distribution, drug metabolism, drug excretion, CYP enzymes, hormonal fluctuations, menstrual cycle, pregnancy, glomerular filtration rate, gastric emptying, body fat content, personalized treatment
- MeSH terms
- Animals, Cytochrome P-450 Enzyme System, Pharmaceutical Preparations, Female, Humans, Male, Pharmacokinetics, Sex Characteristics, Sex Factors, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.